|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
A randomised phaseIIstudy of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) inhigherâÃÂÃÂRisk MDSor low blastAML:GFM's “pick a winner” trial, with the impact of somatic mutations |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
Več možnosti |
|
|
© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno
|